Table 2. Relations between recurrence patterns and expressions of human gastric mucin, MUC6, MUC2 and CDIO.
| Peritoneal (n=60) | Haematogenous (n=32) | Locoregional (n=18) | Control (n=116) | |
|---|---|---|---|---|
| Human gastric mucina | ||||
| Negative | 16 (26.7%) | 18 (56.3%) | 6 (33.3%) | 53 (45.7%) |
| Positive | 44 (73.3%) | 14 (43.8%) | 12 (66.7%) | 63 (54.3%) |
| MUC6 | ||||
| Negative | 23 (38.3%) | 18 (56.3%) | 6 (33.3%) | 43 (37.1%) |
| Positive | 37 (61.7%) | 14 (43.8%) | 12 (66.7%) | 73 (62.9%) |
| MUC2b | ||||
| Negative | 42 (70.0%) | 20 (62.5%) | 9 (50.0%) | 45 (38.8%) |
| Positive | 18 (30.0%) | 12 (37.5%) | 9 (50.0%) | 71 (61.2%) |
| CD10c | ||||
| Negative | 51 (85.0%) | 18 (56.3%) | 15 (83.3%) | 89 (76.7%) |
| Positive | 9 (15.0%) | 14 (43.8%) | 3 (16.7%) | 27 (23.3%) |
a
P=0.01 (peritoneal vs haematogenous) and P=0.022 (peritoneal vs control).
b
P=0.0002 (peritoneal vs control) and P=0.028 (haematogenous vs control).
c
P=0.0054 (peritoneal vs haematogenous) and P=0.039 (haematogenous vs control).